BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
62.87
+0.13 (0.21%)
Apr 25, 2025, 12:36 PM EDT - Market open

BioMarin Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
12,05612,52718,16219,23416,22015,918
Upgrade
Market Cap Growth
-31.03%-31.03%-5.57%18.57%1.90%4.81%
Upgrade
Enterprise Value
11,52712,19918,13219,05116,22915,917
Upgrade
Last Close Price
62.7465.7396.42103.4988.3587.69
Upgrade
PE Ratio
28.3829.35108.34135.87-18.64
Upgrade
Forward PE
14.5517.8638.9839.0085.7975.56
Upgrade
PS Ratio
4.184.397.519.188.798.56
Upgrade
PB Ratio
2.122.213.674.183.803.88
Upgrade
P/TBV Ratio
2.342.444.104.734.414.56
Upgrade
P/FCF Ratio
24.6825.70290.28350.0677.63-
Upgrade
P/OCF Ratio
21.0021.87114.04109.3453.26186.47
Upgrade
PEG Ratio
0.800.721.070.862.661.75
Upgrade
EV/Sales Ratio
4.044.287.509.098.798.56
Upgrade
EV/EBITDA Ratio
17.3018.3062.49121.62481.221186.81
Upgrade
EV/EBIT Ratio
20.2221.4097.60348.42--
Upgrade
EV/FCF Ratio
23.6525.03289.80346.7477.67-
Upgrade
Debt / Equity Ratio
0.110.110.230.240.260.28
Upgrade
Debt / EBITDA Ratio
0.930.933.736.5823.5643.10
Upgrade
Debt / FCF Ratio
1.301.3018.1220.385.38-
Upgrade
Asset Turnover
0.410.410.370.340.310.35
Upgrade
Inventory Turnover
0.500.500.530.601.491.67
Upgrade
Quick Ratio
2.962.961.452.982.543.07
Upgrade
Current Ratio
5.335.332.514.674.164.76
Upgrade
Return on Equity (ROE)
8.05%8.05%3.51%3.19%-1.53%23.63%
Upgrade
Return on Assets (ROA)
5.15%5.15%1.76%0.55%-0.78%-1.09%
Upgrade
Return on Capital (ROIC)
5.76%5.76%1.97%0.61%-0.87%-1.24%
Upgrade
Return on Capital Employed (ROCE)
8.90%8.90%3.30%0.90%--
Upgrade
Earnings Yield
3.55%3.41%0.92%0.74%-0.40%5.37%
Upgrade
FCF Yield
4.05%3.89%0.34%0.29%1.29%-0.18%
Upgrade
Buyback Yield / Dilution
-2.67%-2.67%-1.39%-3.34%4.61%-7.06%
Upgrade
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q